Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome

被引：6
|
作者：
Moran, Lisa J. [1 ]
Noakes, Manny [2 ]
Wittert, Gary A. [3 ]
Clifton, Peter M. [4 ]
Norman, Robert J. [1 ]
机构：
[1] Univ Adelaide, Robinson Inst, Adelaide, SA 5006, Australia
[2] CSIRO Food & Nutr Sci, Adelaide, SA 5000, Australia
[3] Univ Adelaide, Royal Adelaide Hosp, Discipline Med, Adelaide, SA 5005, Australia
[4] Univ S Australia, Baker IDI Heart & Diabet Inst, Adelaide, SA 5001, Australia
来源：
REPRODUCTIVE BIOMEDICINE ONLINE | 2012年 / 25卷 / 05期
基金：
英国医学研究理事会;
关键词：
cardiovascular disease; inflammation; polycystic ovary syndrome; weight loss; GRADE CHRONIC INFLAMMATION; CARDIOVASCULAR RISK; OBESE WOMEN; MEN;
D O I：
10.1016/j.rbmo.2012.07.013
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Polycystic ovary syndrome (PCOS) is associated with increased cardiovascular disease risk. The effect of weight loss on the vascular inflammatory markers plasminogen activator inhibitor-1 (PAI-1), asymmetric dimethylarginine (ADMA), soluble vascular cell adhesion molecule-1 (sVCAM-1) and intracellular adhesion molecule-1 (sICAM-1) is unknown. Overweight women with (n = 14) and without (n = 13) PCOS of comparable age and body mass index undertook an 8-week weight-loss programme. Women with PCOS had elevated PAI-1, sVCAM-1 and sICAM-1 before and after weight loss compared with the controls. For all women, sVCAM-1 (P = 0.026) and sICAM-1 (P = 0.04) decreased with weight loss. Women with PCOS have elevated inflammatory markers, which are partially reduced by weight loss. (C) 2012, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：500 / 503
页数：4
相关论文
共 50 条
  • [21] Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
    Panico, Annalisa
    Messina, Giovanni
    Lupoli, Gelsy Arianna
    Lupoli, Roberta
    Cacciapuoti, Marianna
    Moscatelli, Fiorenzo
    Esposito, Teresa
    Villano, Ines
    Valenzano, Anna
    Monda, Vincenzo
    Messina, Antonietta
    Precenzano, Francesco
    Cibelli, Giuseppe
    Monda, Marcellino
    Lupoli, Giovanni
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 423 - 429
  • [22] Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome
    Koiou, Ekaterini
    Tziomalos, Konstantinos
    Katsikis, Ilias
    Kandaraki, Eleni A.
    Kalaitzakis, Emmanuil
    Delkos, Dimitrios
    Vosnakis, Christos
    Panidis, Dimitrios
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (01) : 20 - 24
  • [23] Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome
    Salama, Amany Alsayed
    Amine, Ezzat Khamis
    Salem, Hesham Abd Elfattah
    El Fattah, Nesrin Kamal Abd
    [J]. NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2015, 7 (07) : 310 - 316
  • [24] Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance
    Martins, Wellington de Paula
    Soares, Gustavo Mafaldo
    Vieira, Carolina Sales
    dos Reis, Rosana Maria
    Silva de Sa, Marcos Felipe
    Ferriani, Rui Alberto
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2009, 31 (03): : 111 - 116
  • [25] METABOLIC SYNDROME: PARTICULARITIES IN OVERWEIGHT WOMEN WITH POLYCYSTIC OVARY SYNDROME AS COMPARED WITH OBESE WOMEN WITHOUT OVARIAN DYSFUNCTION?
    Stoian, Dana
    Craciunescu, Mihaela
    Nitu, R.
    Navolan, D.
    Dumitru, C.
    Craina, M.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (03): : 690 - 698
  • [26] The Impact of Weight Loss on Ovarian Morphology in Obese Women with Polycystic Ovary Syndrome
    Jarrett, Brittany Y.
    Capellan, Pamela
    Lujan, Marla E.
    [J]. FASEB JOURNAL, 2017, 31
  • [27] The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study
    Rasmussen, Christina B.
    Lindenberg, Svend
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [28] Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
    Jiskoot, Geranne
    Dietz de Loos, Alexandra
    Timman, Reinier
    Beerthuizen, Annemerle
    Laven, Joop
    Busschbach, Jan
    [J]. BRAIN AND BEHAVIOR, 2022, 12 (07):
  • [29] Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses
    Harborne, LR
    Sattar, N
    Norman, JE
    Fleming, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08): : 4593 - 4598
  • [30] Longitudinal weight gain and lifestyle factors in women with and without polycystic ovary syndrome
    Awoke, Mamaru Ayenew
    Earnest, Arul
    Joham, Anju
    Hodge, Allison
    Brown, Wendy
    Teede, Helena
    Moran, Lisa
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 20 - 20
12345